DRMA — DERMATA THERAPEUTICS INC
As of Q2 2026, 3 SEC-registered investment managers reported holding DRMA (DERMATA THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $47.73K across 37.00K shares. That is -55.9% by share count (-46.94K shares) versus the previous quarter, while reported value moved -53.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 2 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
DRMA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Two Sigma Investments history | Q4 2021 | 18.70K | $33.00K | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 20.20K | $26.06K | 0.00% | Reduce |
| UBS Group AG history | Q2 2026 | 16.80K | $21.67K | 0.00% | Reduce |
| Bank of America Corp history | Q4 2025 | 3.46K | $8.02K | 0.00% | Add |
| Citadel Advisors history | Q1 2024 | 17.49K | $7.03K | 0.00% | New |
| Fidelity Management & Research (FMR) history | Q3 2022 | 10.00K | $5.00K | 0.00% | New |
| Wells Fargo & Co history | Q1 2025 | 2.00K | $2.16K | 0.00% | Reduce |
| JPMorgan Chase & Co history | Q4 2025 | 696 | $1.61K | 0.00% | New |
| Renaissance Technologies history | Q1 2023 | 26.40K | $34 | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 2 | $3 | 0.00% | New |
| Citigroup Inc history | Q1 2026 | 1 | $1 | 0.00% | New |
New Positions (Q2 2026)
- Morgan Stanley 2 sh · $3
Fully Exited (vs previous quarter)
- Citigroup Inc sold 1 sh · $1
Fund Position History — shares by quarter (top 11 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | 15.86K | 26.67K | 26.67K | 26.67K | 26.67K | 26.67K | — | — | 12.24K | 12.24K | 12.24K | — | — | — | 20.41K | 27.39K | — | — | 48.33K | 20.20K |
| UBS Group AG | 189 | — | 4.32K | 11.21K | 14.80K | 37.31K | 3.44K | 7.01K | 131 | — | — | 1.71K | 1.50K | 13.87K | 70.29K | 90.95K | 10.05K | 1.24K | 35.61K | 16.80K |
| Morgan Stanley | — | 500 | 3 | — | — | 562 | — | — | — | — | — | — | — | — | — | — | — | — | — | 2 |
| JPMorgan Chase & Co | — | 12.14K | 569 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 696 | — | — |
| Bank of America Corp | — | — | — | — | — | — | — | — | — | — | — | 3 | 10 | 16 | 21 | 31 | 4 | 3.46K | — | — |
| Citigroup Inc | — | — | — | 48.94K | — | — | — | — | — | — | — | — | — | — | — | 60 | — | — | 1 | — |
| Citadel Advisors | — | — | — | 79.97K | — | — | — | 17.19K | — | — | 17.49K | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | — | — | — | — | 10.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | 39.25K | — | — | — | — | 26.40K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Two Sigma Investments | — | 18.70K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Wells Fargo & Co | 16 | 16 | 11.02K | 11.02K | 24.42K | 24.44K | 1.53K | 702 | 702 | 703 | 705 | 45 | 2.04K | 2.04K | 2.00K | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details